Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs

BACKGROUND: Long-term monotherapy with nucleos(t)ide analogs (NAs) represents the treatment option for the majority of patients with chronic hepatitis B (CHB), an aging population with a greater likelihood of comorbidities. We assessed the prevalence of concurrent non-hepatic diseases and the safety...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Gastroenterol
Main Authors: Siakavellas, Spyros, Goulis, John, Manolakopoulos, Spilios, Triantos, Christos, Gatselis, Nikolaos, Tsentemidou, Eva, Kranidioti, Hariklia, Ζisimopoulos, Κonstantinos, Τsoulas, Christos, Dalekos, George, Papatheodoridis, George
Formato: Artigo
Idioma:Inglês
Publicado em: Hellenic Society of Gastroenterology 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7774663/
https://ncbi.nlm.nih.gov/pubmed/33414625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2020.0525
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados